Loens, Sebastian
Verrel, Julius
Herrmann, Vera-Maria
Kienzle, Amrei
Tzvi, Elinor
Weissbach, Anne
Junker, Johanna
Münchau, Alexander
Bäumer, Tobias
Funding for this research was provided by:
Bundesministerium für Bildung, Wissenschaft und Forschung (01GM1514A)
Deutsche Forschungsgemeinschaft (SFB936, WE5919/2-1)
Else-Kröner Fresenius Foundation (2018_A55)
Universität zu Lübeck
Article History
Received: 23 November 2020
Accepted: 11 March 2021
First Online: 1 April 2021
Competing interests
: A.M. receives honoraria from Ipsen and Merz Pharmaceuticals. He is member of the advisory boards of Merz Pharmaceuticals<b>.</b> T.B. receives honoraria from Merz Pharmaceuticals, Allergan and Ipsen Pharma. He is member of the advisory boards of Merz Pharmaceuticals, Allergan and Ipsen Pharma and receives consultancies from Merz Pharmaceuticals and Allergan. The other authors declare no competing interests.